The Future of Multiple Sclerosis Care
New Treatment Paradigms and Their Real-World Impacts
Conventional MS care, which follows a stepwise treatment escalation path, has recently been challenged. The new approach promotes early and aggressive use of potent medications beginning immediately upon diagnosis. What Real-World consequences does this change in treatment bring? How might this innovative strategy revolutionize the lives of those affected by this challenging neurological condition?
Our experts Prof. Dr. med. Tjalf Ziemssen, Head of the Center for Clinical Neurosciences, Professor of Clin. Neurosciences, Dresden University Hospital and PD Dr. med. Benjamin Friedrich, Co-Founder & CMO, Temedica discussed these questions in a 30-minutes webinar.
The webinar is held in German.
The experts covered:
The latest research data on the early and aggressive use of MS treatment.
Potential benefits, risks, and transformative implications of this paradigm shift in MS care.
How Real-World Evidence can help to understand challenges of multiple sclerosis medication.
and many more
Prof. Dr. med. Tjalf Ziemssen
Head of the Center for Clinical Neurosciences, Professor of Clin. Neurosciences
Dresden University Hospital
PD Dr. med. Benjamin Friedrich
Chief Medical Officer,